Skip to main content
Caplight Logo









Enbiosis

Enbiosis

Private
LondonHealthcare & Life Scienceshttps://enbiosis.com/

Last Round

VC Round

Jan 22, 2024

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Enbiosis is a biotechnology company that provides AI-powered gut health solutions for personalized care and precision nutrition.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI, Vertical SaaS

Business Model

B2B

Customer Profile

Usage-Based SaaS, Data as a Service, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

gut microbiome analysismicrobiome testingpersonalized nutritionmicrobiome companyB2B healthcaremedical AIgut healthprecision nutritionhealthcare SaaSwhole genome sequencinggut techpractitioner toolsnutraceutical formulationIBS treatmenthealthcare APIwhite-label SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Enbiosis Comparables

Compare Enbiosis with similar companies based on industry and business-model similarity.

Enbiosis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biohm Technologies
78%
Biomesight
77%
Microba Life Sciences Ltd
76%

Enbiosis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 22, 2024
AcceleratorMay 1, 2023
SeedMay 27, 2021

Key People

Founding team and executive leadership

Ömer Özkan

CEO Founder

Founding Team

Pelin Kumcular

CEO Office I Team Coordinating Manager

Executive Team

Enbiosis Investors

Notable investors and investment history

Enbiosis investors
InvestorRounds
QINVEST Portföy Yönetimi A.Ş.VC Round
London & PartnersAccelerator
Pragma Capital PartnersVC Round, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 72% MoM.

  • Jun 18, 2026

    Monthly visitors increased 138% MoM, reaching 3.9K.

Enbiosis Filings

Explore SEC and related filing metadata, where available.

Enbiosis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Enbiosis's valuation, stock price, and market status.

Is Enbiosis a public or private company?

Enbiosis is a private company.

What is the current stock price of Enbiosis?

Enbiosis is a private company with no public stock price. No recent secondary market data is available.

How much is Enbiosis worth (valuation)?

Valuation information for Enbiosis is not publicly available.

Can I buy Enbiosis stock?

Enbiosis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Enbiosis's last funding round?

Enbiosis's most recent funding round was VC Round on January 22, 2024.

Who are the main investors in Enbiosis?

Key investors in Enbiosis include QINVEST Portföy Yönetimi A.Ş., Grow London, Pragma Capital Partners.

Will Enbiosis IPO soon?

No public IPO plans have been announced for Enbiosis.

How can I track Enbiosis secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Enbiosis's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range20
Year Founded2019
Last FundingJan 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?